Yale Bulletin and Calendar

December 15, 2000Volume 29, Number 14



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

PRODUCTION SCHEDULE

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Study: Caffeine doesn't create dependence
on over-the-counter pain relievers

A review by a committee composed of international scientists and chaired by a Yale researcher has found no evidence that caffeine in over-the-counter pain relievers leads to dependence.

A possible link between caffeine in analgesics, such as aspirin and acetaminophen, and resulting dependency had aroused considerable attention in Europe. In fact, various groups in Germany, Austria and Switzerland sought protective regulatory action. The committee to review the problem was chosen by federal drug authorities in the three countries as well as by the pharmaceutical industry.

The group of international scientists was chaired by Dr. Alvan R. Feinstein, Sterling Professor of Medicine and Epidemiology at Yale School of Medicine. They reviewed articles in peer-reviewed journals, editorials and any other appropriate publications. Because the literature provides only rare data on the role of caffeine in analgesic use, the panel also interpreted analgesic activity in studies on the abuse potential of caffeine in coffee or other beverages.

They noted that caffeine has a synergistic action with analgesics, enhancing their effectiveness. But they found that withdrawal from the use of analgesics containing caffeine is not likely to stimulate or sustain continued use of analgesics.

"Although caffeine has a dependence potential, the potential is low," the researchers concluded in the study published in the journal Clinical Pharmacology and Therapeutics. "Suspicions that caffeine combinations with analgesics might lead to dependence behavior are not supported by data, except in formerly used combinations with phenacetin."

Phenacetin is a pain killer, like other analgesics, that was withdrawn from the market about 10 years ago because of suspected renal toxicity.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Yale experts to explore 'Democratic Vistas' in DeVane Lecture series

Three Elis win Rhodes Scholarships

State honors Yale's efforts in 'revitalizing' urban areas


ENDOWED PROFESSORSHIPS

Comedian alternates wit, seriousness in election analysis

'Circa 1701' features portraits of contemporaries of Elihu Yale

Religion and communication are among the important issues as terminally ill . . .

Stern recalls New Haven's role as 'original Model City'

Study: Caffeine doesn't create dependence on over-the-counter pain relievers

Exhibition will explore 'the opportunistic transformation' at the heart of African art

Tumbling Time: A Photo Essay

Service to honor memory of Yale employee Lucy Cunningham

In the News

Yale Scoreboard



Bulletin Home|Visiting on Campus| Calendar of Events|Bulletin Board

Classified Ads|Search Archives|Production Schedule|Bulletin Staff

Public Affairs Home|News Releases| E-Mail Us|Yale Home Page